OptumRx: Cigna-Healthspring Medicare Part D Plans Point-of-Sale Edits on Multi-Ingredient Compounds

Effective: January 1, 2016

Author: Kerri Williams/Wednesday, January 13, 2016/Categories: APCI Choice

As of January 1, 2016, claims for Multi-Ingredient Compounds (MICs) will process according to the Cigna- HealthSpring Medicare Part D Formularies. 

This means that each ingredient within a compound will pay or reject based on the specific ingredient‟s Formulary status. Part D products with Prior Authorization (PA), including B vs. D and Step Therapy (ST) will be subject to Formulary rules. Non-Formulary (NF) ingredients will reject as such.

-The pharmacy will have the option to: 

  • Submit a coverage determination for the rejected ingredients (PA, ST or NF); or 
  • Resubmit a MIC claim with the rejected ingredients (PA, ST or NF) by submitting a submission clarification code (SCC) value of „08‟. This means that the non-covered drugs will process at $0 and by submitting the „08‟ that you are accepting payment for this amount as the entire payment. CMS does not allow pharmacies to charge the beneficiaries any more than their adjudicated co-payment. 

Please download attached PDF file for more information.

Comments are only visible to subscribers.